PCP
ANIP icon

Proficio Capital Partners’s ANI Pharmaceuticals ANIP Stock Holding History

Proficio Capital Partners’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-53
Closed -$4K – 214
2019
Q2 		$4K Buy
53
+37
+231% +$2.63K ﹤0.01% 1264
2019
Q1 		$1K Buy
+16
New +$941 ﹤0.01% 1466

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Proficio Capital Partners's ANIP Position: Q3 2019 in Review

Proficio Capital Partners sold out of ANI Pharmaceuticals (ANIP) in Q3 2019, closing a stake of 53 shares — an estimated $4K sold.

Proficio Capital Partners first reported a position in ANIP in Q1 2019 and held it in 2 quarters. The position peaked at $4K in Q2 2019. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

  • Proficio Capital Partners reported no remaining ANI Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 53 ANI Pharmaceuticals shares in Q3 2019, an estimated $4K.
  • Proficio Capital Partners first reported a position in ANI Pharmaceuticals in Q1 2019 and held it in 2 quarters.
  • Proficio Capital Partners's ANI Pharmaceuticals position peaked at $4K in Q2 2019.
  • 190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on Proficio Capital Partners's 13F filing for Q3 2019, filed 13 Nov 2019.